This company listing is no longer active
이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Generex Biotechnology 관리
관리 기준 확인 2/4
주요 정보
Joe Moscato
최고 경영자
n/a
총 보상
| CEO 급여 비율 | n/a |
| CEO 임기 | 5.4yrs |
| CEO 소유권 | 0.4% |
| 경영진 평균 재임 기간 | 5.4yrs |
| 이사회 평균 재임 기간 | 5.4yrs |
최근 관리 업데이트
Recent updates
CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Apr 30 2021 | n/a | n/a | -US$37m |
| Jan 31 2021 | n/a | n/a | -US$52m |
| Oct 31 2020 | n/a | n/a | -US$35m |
| Jul 31 2020 | US$623k | US$623k | -US$33m |
| Apr 30 2020 | n/a | n/a | -US$26m |
| Jan 31 2020 | n/a | n/a | -US$31m |
| Oct 31 2019 | n/a | n/a | -US$36m |
| Jul 31 2019 | US$103k | n/a | -US$9m |
| Apr 30 2019 | n/a | n/a | US$10m |
| Jan 31 2019 | n/a | n/a | US$24m |
| Oct 31 2018 | n/a | n/a | US$27m |
| Jul 31 2018 | US$100k | n/a | US$36m |
| Apr 30 2018 | n/a | n/a | US$9m |
| Jan 31 2018 | n/a | n/a | -US$37m |
| Oct 31 2017 | n/a | n/a | -US$43m |
| Jul 31 2017 | US$50k | n/a | -US$70m |
보상 대 시장: Insufficient data to establish whether Joe's total compensation is reasonable compared to companies of similar size in the US market.
보상과 수익: Joe's compensation has increased whilst the company is unprofitable.
CEO
Joe Moscato (57 yo)
5.4yrs
테뉴어
US$623,082
보상
Mr. Joseph Moscato, also known as Joe, serves as Chief Executive Officer and Vice-Chairman of the Board at NuGenerex Immuno-Oncology, Inc. and served as its Chairman of the Board. Mr. Moscato has been the...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO, President & Chairman of the Board | 5.4yrs | US$623.08k | 0.36% $ 219.0 | |
| CFO & Treasurer | 5.4yrs | US$10.00k | 0% $ 0 | |
| Chief Operating Officer | 4.4yrs | US$566.44k | 0% $ 0 | |
| Chief Investment Officer & Director | 5.4yrs | US$18.88k | 0% $ 0 | |
| Chief Legal Officer & Chief Administrative Officer | 2.8yrs | US$424.83k | 0% $ 0 | |
| Chief Commercial Officer | 3.4yrs | 데이터 없음 | 1.08% $ 658.9 | |
| Chief Scientific Officer & Chief Medical Officer | 5.4yrs | 데이터 없음 | 0% $ 0 | |
| Chief Marketing Officer | 3.6yrs | 데이터 없음 | 데이터 없음 | |
| Executive Vice President of Research & Drug Development | 5.4yrs | US$68.33k | 0% $ 0 |
5.4yrs
평균 재임 기간
56.5yo
평균 연령
경험이 풍부한 관리: GNBT's management team is seasoned and experienced (5.4 years average tenure).
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO, President & Chairman of the Board | 5.4yrs | US$623.08k | 0.36% $ 219.0 | |
| Chief Investment Officer & Director | 5.4yrs | US$18.88k | 0% $ 0 | |
| Independent Director | 18.3yrs | US$47.20k | 0% $ 0 | |
| Independent Director | 5.4yrs | US$18.88k | 0.26% $ 160.2 | |
| Independent Director & Member of Scientific Advisory Board | 11.8yrs | US$47.20k | 0% $ 0 | |
| Independent Director | 11yrs | US$118.33k | 0% $ 0 | |
| Member of Scientific Advisory Board | 1.7yrs | 데이터 없음 | 데이터 없음 | |
| Independent Director | 3.2yrs | 데이터 없음 | 0% $ 0 | |
| Member of Scientific Advisory Board | 1.7yrs | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | 1.7yrs | 데이터 없음 | 데이터 없음 |
5.4yrs
평균 재임 기간
59yo
평균 연령
경험이 풍부한 이사회: GNBT's board of directors are considered experienced (5.4 years average tenure).